LENSAR, Inc. (LNSR) Financial Statements (2025 and earlier)

Company Profile

Business Address 2800 DISCOVERY DRIVE
ORLANDO, FL 32826
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments22,45518,08014,21317,91024,06424,920
Cash and cash equivalent16,26310,4428,28713,95820,62124,920
Short-term investments6,1927,6385,9263,9523,443 
Receivables6,4804,7256,2304,3524,3244,112
Inventory, net of allowances, customer advances and progress billings11,42814,89217,93317,81615,68917,481
Inventory11,42814,89217,93317,81615,68917,481
Other undisclosed current assets1,6161,7051,8532,3572,3672,132
Total current assets:41,97939,40240,22942,43546,44448,645
Noncurrent Assets
Operating lease, right-of-use asset 2,466   2,141 
Property, plant and equipment664677716747679482
Long-term investments and receivables1,1601,4462,3012,4101,7711,131
Long-term investments  4941,2341,236492 
Accounts and financing receivable, after allowance for credit loss1,1609521,0671,1741,2791,131
Intangible assets, net (including goodwill)6,1126,3446,57610,75111,02511,298
Intangible assets, net (excluding goodwill)6,1126,3446,57610,75111,02511,298
Other noncurrent assets2,6151,8471,9652,0642,2072,341
Other undisclosed noncurrent assets11,30112,3039,6197,7275,3186,956
Total noncurrent assets:24,31822,61721,17723,69923,14122,208
TOTAL ASSETS:66,29762,01961,40666,13469,58570,853
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,8029,6678,3838,3009,7249,393
Accounts payable5,9953,8674,1214,1204,0073,936
Accrued liabilities6,8075,8004,2624,1805,7175,457
Deferred revenue1,6771,4371,4141,5821,3491,064
Other undisclosed current liabilities524574569564559554
Total current liabilities:15,00311,67810,36610,44611,63211,011
Noncurrent Liabilities
Liabilities, other than long-term debt2,7921,5241,7262,1442,3202,453
Other liabilities702205262537570560
Operating lease, liability2,0901,3191,4641,6071,7501,893
Other undisclosed noncurrent liabilities29,85612,29511,8857,9628,4577,259
Total noncurrent liabilities:32,64813,81913,61110,10610,7779,712
Total liabilities:47,65125,49723,97720,55222,40920,723
Temporary equity, including noncontrolling interest13,78413,78413,78413,74713,74713,747
Equity
Equity, attributable to parent4,86222,73823,64531,83533,42936,383
Common stock116116115114113112
Additional paid in capital148,035147,200146,627145,770145,203144,236
Accumulated other comprehensive income (loss)615(6)(1)4 
Accumulated deficit(143,295)(124,593)(123,091)(114,048)(111,891)(107,965)
Total equity:4,86222,73823,64531,83533,42936,383
TOTAL LIABILITIES AND EQUITY:66,29762,01961,40666,13469,58570,853

Income Statement (P&L) ($ in thousands)

3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
Revenues16,73113,53912,63610,58812,1059,795
Operating lease, lease income1,9091,7241,9521,9471,6041,524
Cost of revenue(9,623)(7,273)(5,823)(4,924)(6,956)(4,918)
Gross profit:7,1086,2666,8135,6645,1494,877
Operating expenses(12,127)(7,511)(12,093)(8,514)(8,110)(6,917)
Other undisclosed operating income 3,729     
Operating loss:(1,290)(1,245)(5,280)(2,850)(2,961)(2,040)
Nonoperating income
(Other Nonoperating income)
149153160198233265
Loss from continuing operations before equity method investments, income taxes:(1,141)(1,092)(5,120)(2,652)(2,728)(1,775)
Other undisclosed loss from continuing operations before income taxes (21,399)   (2,852) 
Loss from continuing operations:(22,540)(1,092)(5,120)(2,652)(5,580)(1,775)
Other undisclosed net income (loss)3,838  4951,654 
Net loss:(18,702)(1,092)(5,120)(2,157)(3,926)(1,775)
Other undisclosed net income (loss) attributable to parent  (410)(3,923)  4,343
Net income (loss) attributable to parent:(18,702)(1,502)(9,043)(2,157)(3,926)2,568
Other undisclosed net loss available to common stockholders, basic      (1,135)
Net income (loss) available to common stockholders, basic:(18,702)(1,502)(9,043)(2,157)(3,926)1,433
Other undisclosed net loss available to common stockholders, diluted      (4,233)
Net loss available to common stockholders, diluted:(18,702)(1,502)(9,043)(2,157)(3,926)(2,800)

Comprehensive Income ($ in thousands)

3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
Net loss:(18,702)(1,092)(5,120)(2,157)(3,926)(1,775)
Comprehensive loss:(18,702)(1,092)(5,120)(2,157)(3,926)(1,775)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(9)(389)(3,928)(5)4 
Comprehensive loss, net of tax, attributable to parent:(18,711)(1,481)(9,048)(2,162)(3,922)(1,775)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: